Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Q5QC
|
|||
Former ID |
DNC010606
|
|||
Drug Name |
EMD-534085
|
|||
Synonyms |
EMD-534085; 858668-07-2; EMD534085; EMD 534085; UNII-AL67QX8036; CHEMBL1077204; AL67QX8036; 1-(2-(Dimethylamino)ethyl)-3-(((2R,4aS,5R,10bS)-5-phenyl-9-(trifluoromethyl)-3,4,4a,5,6,10b-hexahydro-2H-pyrano(3,2-C)quinolin-2-yl)methyl)urea; 1-[2-(dimethylamino)ethyl]-3-{[(2R,4aS,5R,10bS)-5-phenyl-9-(trifluoromethyl)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinolin-2-yl]methyl}urea
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Haematological malignancy [ICD-11: 2B33.Y] | Phase 1 | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C25H31F3N4O2
|
|||
Canonical SMILES |
CN(C)CCNC(=O)NCC1CCC2C(NC3=C(C2O1)C=C(C=C3)C(F)(F)F)C4=CC=CC=C4
|
|||
InChI |
1S/C25H31F3N4O2/c1-32(2)13-12-29-24(33)30-15-18-9-10-19-22(16-6-4-3-5-7-16)31-21-11-8-17(25(26,27)28)14-20(21)23(19)34-18/h3-8,11,14,18-19,22-23,31H,9-10,12-13,15H2,1-2H3,(H2,29,30,33)/t18-,19+,22+,23+/m1/s1
|
|||
InChIKey |
MARIUIDCPUZLKZ-FUKQBSRTSA-N
|
|||
CAS Number |
CAS 858668-07-2
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Kinesin spindle messenger RNA (KIF11 mRNA) | Target Info | Inhibitor | [2] |
Reactome | MHC class II antigen presentation | |||
Kinesins | ||||
WikiPathways | MHC class II antigen presentation | |||
Kinesins |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027260) | |||
REF 2 | The discovery and optimization of hexahydro-2H-pyrano[3,2-c]quinolines (HHPQs) as potent and selective inhibitors of the mitotic kinesin-5. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1491-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.